Targeting the prostate for destruction through a vascular address

Proceedings of the National Academy of Sciences of the United States of America

Volumn 99, Issue 3, 2002, Pages 1527-1531

  Arap, Wadih ^a,c   Haedicke, Wolfgang ^a,d   Bernasconi, Michele ^a   Kain, Renate ^b,e   Rajotte, Daniel ^a,f   Krajewski, Stanislaw ^a   Ellerby, H Michael ^a,g   Bredesen, Dale E ^a,g   Pasqualini, Renata ^a,c   Ruoslahti, Erkki ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY HOSPITAL GRAZ   (Austria)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^g BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; HEPTAPEPTIDE; PEPTIDE LIBRARY; SERYLMETHIONYLSERYLISOLEUCYLALANYLARGINYLLEUCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIOPHAGE; CANCER CELL DESTRUCTION; CANCER PREVENTION; CONTROLLED STUDY; DRUG DESIGN; DRUG SPECIFICITY; DRUG SYNTHESIS; DRUG TARGETING; MALE; MOUSE; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROSTATE CARCINOMA;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BACTERIOPHAGES; ENDOTHELIUM, VASCULAR; GENE LIBRARY; HUMANS; INTRACELLULAR MEMBRANES; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; PEPTIDE LIBRARY; PROSTATIC NEOPLASMS;

ANIMALIA; MUS MUSCULUS;

EID: 0037022366     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.241655998     Document Type: Article

References (15)